Transdermal Skin Patches Market is Estimated to Witness High Growth Owing to Rising Prevalence of Chronic Diseases
Transdermal Skin Patches Market |
The
transdermal skin patches market has witnessed significant growth over the past
few years owing to growing demand in applications such as pharmaceuticals and
medical therapy. Transdermal skin patches are drug delivery systems used to
deliver a therapeutically effective amount of medication through the skin and
into the bloodstream. They provide several advantages over conventional oral
drug delivery methods including controlled release of drugs at predetermined
rates, non-invasiveness, and direct access to systemic circulation. Owing to
these benefits, transdermal skin patches are widely being used for delivery of
nicotine, hormones, analgesics and various other drugs.
The
Global transdermal skin patches market is estimated to be valued at US$ 9773.27
Bn in 2024 and is expected to exhibit a CAGR of 23% over the forecast period
2024 To 2031.
Key Takeaways
Key players operating in the transdermal skin patches are Omsk Carbon Group,
Tokai Carbon Co., Ltd., Atlas Organics Private Limited, Continental Carbon
Company, Birla Carbon, Cabot Corporation, International China Oak Investment
Holdings Co., Ltd., Himadri Speciality Chemical Ltd, Philips Carbon Black
Limited, Orion Engineered Carbons GmbH, Ralson.
Key opportunities in the market include growing focus on developing generic
transdermal patches and expansion in emerging countries. Pharmaceutical
companies are also focusing on development of advanced transdermal patches for
delivery of large molecule drugs.
The global expansion of the Transdermal
Skin Patches Market Size is mainly driven by the rising prevalence of
chronic diseases worldwide. According to the WHO, chronic diseases are the
leading cause of mortality in the world, representing 63% of all deaths
globally. Growth in the aging population is also fueling the demand for
transdermal patches significantly.
Market drivers
The major driver for the growth of transdermal skin patches market is the
rising prevalence of chronic diseases including diabetes, hypertension and
Alzheimer's disease across the globe. As per the International Diabetes
Federation, around 537 million adults were living with diabetes in 2021
worldwide and the number is projected to rise to 643 million by 2030 and 783
million by 2045. Transdermal patches help in effective management of such
chronic conditions through controlled and sustained drug delivery. Another key
driver is the ability of transdermal patches to provide fast pain relief for
acute conditions compared to oral medications. This is increasing their
adoption for delivery of analgesics and anesthetics.
PEST Analysis
Political: Regulations regarding drug approvals and clinical trials impact
market growth. Favorable regulatory environment and schemes boost R&D
activities.
Economic: Rising healthcare expenditure and affordability drive market demand.
Expanding middle-class population requiring treatment for chronic ailments fuel
market growth.
Social: Growing awareness regarding various skin disorders and availability of
advanced treatment options influence market trends. Increasing incidence of
chronic pain, neurological disorders, and cardiovascular diseases also
contribute to market growth.
Technological: Advanced material science and miniaturization allow development
of highly efficient transdermal patches. Focus on patient comfort, delivery,
and controlled release propels technological innovations in patch design.
Geographical Regions with High Market Concentration
The transdermal skin patches market in terms of value is highly concentrated in
North America and Western Europe. This can be attributed to presence of major
pharmaceutical companies, advanced healthcare infrastructure, high awareness
regarding therapies, and favorable reimbursement policies supporting market
growth in these regions.
Fastest Growing Region
Asia Pacific region is expected to be the fastest growing market for
transdermal skin patches during the forecast period. Growth driving factors
include rising healthcare spending, presence of generic manufacturers,
increasing incidence of chronic diseases, growing geriatric population,
expanding distribution channels, and favorable government initiatives
supporting healthcare sector development in emerging Asian countries.
About Author:
Money Singh is a seasoned content writer with over
four years of experience in the market research sector. Her expertise spans
various industries, including food and beverages, biotechnology, chemical and
materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
Comments
Post a Comment